LIMN Liminatus Pharma, Inc. - Class A Common Stock
$0.17
Price · May 22, 2026
Fundamentals as of May 15, 2026
LIMN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.17
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $34
LIMN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
LIMN
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
LIMN
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
LIMN
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
LIMN
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
LIMN
Peer Median
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LIMN | — | — | — | — | — | — |
| BIAF | — | — | — | — | — | — |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| BCAB | — | -0.6 | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 11
| Metric | Trend | Q1 2026 |
|---|---|---|
| R&D Expense | $400.0K | |
| SG&A Expense | $700.9K | |
| Operating Expenses | $1M | |
| Operating Income | $-1M | |
| Other Non-op | $-22.8K | |
| Net Income | $-1M | |
| EPS (Basic) | $-0.03 | |
| EPS (Diluted) | $-0.03 | |
| Shares (Basic) | 35,999,589 | |
| Shares (Diluted) | 35,999,589 | |
| EBITDA | $-1M |
Balance Sheet 16
| Metric | Trend | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $2M | |
| Prepaid Expense | $870.9K | |
| Current Assets | $3M | |
| PP&E (Net) | $11.7K | |
| Total Assets | $3M | |
| Accounts Payable | $529.8K | |
| Short-term Debt | $1M | |
| Current Liabilities | $3M | |
| Total Liabilities | $3M | |
| Total Debt | $1M | |
| Common Stock | $4.8K | |
| Paid-in Capital | $40M | |
| Retained Earnings | $-40M | |
| Stockholders' Equity | $-132.6K | |
| Liabilities + Equity | $3M | |
| Shares Outstanding | 44,877,633 |
Cash Flow 3
| Metric | Trend | Q1 2026 |
|---|---|---|
| Operating Cash Flow | $-2M | |
| Financing Cash Flow | $4M | |
| Net Change in Cash | $2M |
Profitability 2
| Metric | Trend | Q1 2026 |
|---|---|---|
| ROA | -80.5% | |
| ROE | 1681.5% |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 |
|---|---|---|
| Current Ratio | 1.0 | |
| Quick Ratio | 0.7 | |
| Debt / Equity | -10.9 |
Valuation (TTM) 8
| Metric | Trend | Q1 2026 |
|---|---|---|
| Net Income TTM | $-3M | |
| Market Cap | $8M | |
| Enterprise Value | $7M | |
| P/E | -1.4 | |
| P/B | -58.2 | |
| P / Cash Flow | -3.8 | |
| EV / EBITDA | -6.6 | |
| Earnings Yield | -69.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.